Park Ha Biological Technology Co. Ltd. Ordinary Shares

BYAH | NASDAQ

$2.55

+$0.10 (+4.08%)

Sep 22, 2026, 10:56 AM ET · Market open

Fiscal Quarter Period Ending	Q2 2026 Apr 29, 2026	Q1 2026 Jan 30, 2026	Q4 2025 Oct 30, 2025	Q3 2025 Jul 30, 2025	Q2 2025 Apr 29, 2025	Q4 2024 Oct 30, 2024	Q2 2024 Apr 29, 2024
PE Ratio	-0.10	-0.10	-0.42	-0.64	-0.71	n/a	n/a
PEG Ratio	-0.01	0	0	0.01	n/a	n/a	n/a
PS Ratio	1.42	3.25	3.52	8.14	11.35	n/a	n/a
PB Ratio	1.01	2.29	2.79	3.84	3.31	n/a	n/a
P/FCF Ratio	-6.17	-41.81	-88.40	127.60	57.85	n/a	n/a
P/OCF Ratio	-13.21	-243.16	1.84K	92.54	57.33	n/a	n/a
OCF/S Ratio	-9.04	-9.04	-12.41	-12.41	19.81	n/a	n/a
Debt / Equity Ratio	0.03	0.03	0.05	0.05	0.02	0.05	0.02
Quick Ratio	3.31	3.31	2.88	2.88	3.63	1.82	1.62
Current Ratio	3.36	3.36	2.92	2.92	3.68	1.87	1.71
Asset Turnover	0.17	0.08	0.22	0.11	0.21	n/a	n/a
Interest Coverage	-240.64K	n/a	-211.11K	n/a	-985.78K	n/a	n/a
Return on Equity	-17.05%	-8.52%	-113.36%	-56.68%	-466.68%	n/a	n/a
Return on Assets	-12.31%	-6.15%	-76.08%	-38.04%	-340.10%	n/a	n/a
Return on Invested Capital	-17.06%	-8.63%	-106.19%	-53.09%	-454.08%	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	88.79%	96.36%	86.16%	93.46%	95.28%	n/a	n/a
Net Profit Margin	-73.01%	-73.01%	-352.26%	-352.26%	-1.6K%	n/a	n/a
Pretax Profit Margin	-73.91%	-73.91%	-344.35%	-344.35%	-1.59K%	n/a	n/a
Operating Profit Margin	-76.53%	-76.53%	-344.83%	-344.83%	-1.59K%	n/a	n/a
FCF Margin	-26.94%	-26.94%	-19.15%	-19.15%	19.63%	n/a	n/a
EBITDA Margin	-68.96%	-68.96%	-337.04%	-337.53%	-1.59K%	n/a	n/a